Use

This test is useful for the diagnosis of Krabbe disease and serves as a follow-up testing for evaluating an abnormal newborn screening result for Krabbe disease. It provides diagnostic testing for patients with clinical signs and symptoms suspicious for Krabbe disease. Reduced or absent galactocerebrosidase in leukocytes can indicate a diagnosis of Krabbe disease. However, this test is not intended for carrier detection.